ANN JAMES: Open Payments
NPI 1285692921 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$205 in 10 payments from 6 companies in 2025. Trend: 2023 $527 · 2024 $271 · 2025 $205
Food & beverage: $205
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $105 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: QULIPTA, VRAYLAR, FANAPT, CAPLYTA, Kerendia, TRELEGY ELLIPTA, GARDASIL 9.
Industry payments across IN — which companies pay providers there.
